Replies to post #3922 on Phio Pharmaceuticals Corp (PHIO)

[sabaidii2]

Correct.

At this point, RXI has been making numerous presentations for years. The only deals have been with MirImmune and Thera Neuropharma - two very tiny, very early-stage biotechs. Those companies won't be bringing home the bacon anytime soon.

So far as Big Pharma doing a deal, I think they want to see positive test results first. Deals like Pfizer's 2011 purchase of Excaliard - and subsequent failure of Excaliard's anti-scarring drug (targeting CTGF) - does not bode well for RXI. "Once bitten, twice shy" applies here.